Sunday 8 November 2026 Export MIRA’s income statement to Excel — free account

MIRA Pharmaceuticals, Inc.

MIRA

Healthcare Drug Manufacturers General

EPS: +66.7%
Free cash flow: −50.8%

Quarter to June 2026, against a year earlier

0.57 0.03 +5.56%

Follow MIRA

Alert me

Market cap: $22.7M
P/E: n/m
Fwd P/E: —
Dividend yield: —
F-score: n/a
ROIC: −12,016.1%
Net debt / EBITDA: 1.1×
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(510.93%)	(508.28%)	(589.40%)	(710.85%)
ROA Full definition →		(477.58%)	(456.59%)	(577.42%)	(684.27%)
ROIC Full definition →		(32,898.61%)	0.00%	0.00%	(12,016.10%)
Return on Tangible Assets Full definition →		(378.18%)	(308.99%)	(336.78%)	(381.90%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(0.28)	(0.20)	(0.10)	(0.11)
Free Cash Flow Full definition →		(5.33)	(4.66)	(4.23)	(4.64)
Other line items
Cash ROIC Full definition →		(35.34%)	(21.76%)	(22.57%)	(28.50%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.19	0.15	0.14	0.15
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.28)	(0.20)	(0.10)	(0.11)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates